NCT04106557
- Conditions
- Primary Disease or Condition Being Studied: Angelman Syndrome (AS)
- Locations
-
- Ovid Therapeutics Investigative Site Phoenix, Arizona, United States
- Ovid Therapeutics Investigative Site San Diego, California, United States
- Ovid Therapeutics Investigative Site Chicago, Illinois, United States
- Ovid Therapeutics Investigative Site Boston, Massachusetts, United States